Company: CWAN
Filing Date: 2025-03-31
Form Type: 425
Source: 0001193125-25-067656
Chunk: 4

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-31
Form: 425
Chunk 4
---
 filed with
the SEC on February 26, 2025, the amendment to Clearwater’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 7, 2025, and in the Definitive Proxy
Statement/Prospectus. Information about the directors and executive officers of Enfusion is available in its Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on
March 3, 2025, its definitive proxy statement for its 2024 annual meeting of stockholders, which was filed with the SEC on April 26, 2024, and in the Definitive Proxy Statement/Prospectus. Other information regarding the participants in
the solicitations and a description of their direct and indirect interests, by security holdings or otherwise, are or will be contained in the Definitive Proxy Statement/Prospectus and other relevant materials to be filed with the SEC regarding the
Mergers when they become available. Investors should read the Definitive Proxy Statement/Prospectus carefully before making any voting or investment decisions. Copies of the documents filed with the SEC by Clearwater and Enfusion will be available
free of charge through the website maintained by the SEC at www.sec.gov. Additionally, copies of documents filed with the SEC by Clearwater, including the Definitive Proxy Statement/Prospectus are available free of charge from Clearwater’s
website at investors.clearwateranalytics.com/overview, and copies of documents filed with the SEC by Enfusion, including the Definitive Proxy Statement/Prospectus are available free of charge from Enfusion’s website at ir.enfusion.com.